SKU: Z101439-ABM
Recombinant Human EPO
Human
In Stock
RT
Specifications
| Specification | Details |
|---|---|
| Gene Symbol | EPO |
| Molecular Weight | 20 |
| Source | CHO |
| Purity | >95% as determined by SDS-PAGE |
| Activity | Activity was determined by the dose-dependent proliferation assay using a factor-dependent human erythroleukemic cell line TF-1 and was found to be less than 0.2ng/ml |
| Format | Lyophilized Powder |
| Synonyms | Erythropoietin. Recombinant Human Erythropoietin-Alpha (EPO) |
| Organism | Human |
| Gene ID | 2056 |
| Accession No. | P01588 |
| Background | EPO is predominantly synthesized and secreted by tubular and juxtatubular capillary, endothelial, and interstitial cells of the kidney. Approximately 10-15% of the total amount of EPO comes from extrarenal sources and is predominantly produced by hepatocytes and Kupffer cells of the liver. Approximately 40% of the molecular mass of EPO is due to its glycosylation. Glycosylation is an important factor determining the pharmacokinetic behaviour of EPO in vivo. Non-glycosylated Epo has an extremely short biological half life. Recombinant Human EPO is a glycosylated protein that runs at approximately 35 kDa owing to its glycosylation. |
Catalog Number
Z101439-ABM
Name
Recombinant Human EPO
Price(100 mg)
Pack Size